ClinicalTrials.Veeva

Menu

Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)

P

Princess Grace Hospital Center (CHPG)

Status

Completed

Conditions

Parkinson Disease(PD)
Alzheimer's Dementia
Fronto-Temporal Dementia

Treatments

Other: No intervention. Only survey and normal use of eye-tracking

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

It is commonly admitted that social cognition impairment, like deficit in facial emotion recognition or misinterpretation of others' intentions (Theory of Mind), are associated with social behavior disorders.

This kind of disorders are observed in Fronto-Temporal Dementia (FTD), Alzheimer's Dementia (AD) and Parkinson's Disease (PD), with severe deficits in FTD and lighter deficits in AD and PD.

One explanation might be that patients apply inappropriate visual exploration strategies to decode emotions and intentions of others.

This study aims to test this hypothesis and further to analyse whether different patterns emerge from these pathologies.

Enrollment

70 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalized or coming to perform a consultation, for whom an Eye-Tracking examination is indicated as part of routine care.
  • Sufficient written and oral expression in French.
  • Written informed consent signed by the patient.
  • For the control group: No cognitive impairment (non pathological MMSE (according to age, gender and socio-cultural level), no neurological history, and no psychiatric history (especially anxiety and depressive disorders).
  • For the FTD group: Patient diagnosed according to revised Rascovsky et al. 2011., no neurological history (excepted diagnosed FTD), and no psychiatric history (excepted those related to diagnosed FTD).
  • For the AD group: Patient diagnosed according to DSM-IV-TR criteria, no neurological history (excepted diagnosed AD), and no psychiatric history (excepted those related to diagnosed AD).
  • For the PD group: Patient diagnosed according to NINDS criteria, no neurological history (excepted diagnosed PD), and no psychiatric history (excepted those related to diagnosed PD).

Exclusion criteria

  • General anaesthesia within 3 months.
  • Ophthalmological problems preventing a video-oculography examination.
  • Oculomotor disorders such as "fixation disorders" or "ocular tracking disorders".
  • Cognitive disorders of the type: visual agnosia, visuo-spatial disorder, visuo-perceptual disorder or aphasia.
  • History of stroke.
  • History of alcohol or drug abuse.

Trial design

70 participants in 4 patient groups

Fronto-Temporal Dementia (FTD)
Description:
10 subjects Standard neuropsychological evaluations. Standard Eye-Tracking paradigms.
Treatment:
Other: No intervention. Only survey and normal use of eye-tracking
Alzheimer's Dementia (AD)
Description:
20 subjects Standard neuropsychological evaluations. Standard Eye-Tracking paradigms.
Treatment:
Other: No intervention. Only survey and normal use of eye-tracking
Parkinson's Disease (PD)
Description:
20 subjects Standard neuropsychological evaluations. Standard Eye-Tracking paradigms.
Treatment:
Other: No intervention. Only survey and normal use of eye-tracking
Healthy volunteers
Description:
20 subjects Standard neuropsychological evaluations. Standard Eye-Tracking paradigms.
Treatment:
Other: No intervention. Only survey and normal use of eye-tracking

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems